Greenberg Traurig’s Tel Aviv and Germany offices jointly advised a group of Israeli institutional investors who acquired the Eschborn Plaza office complex in a joint venture lead by Aurec Capital. The group was comprised of Migdal Insurance Group, Bank Leumi Pension Fund, and IDI Insurance Company as well as a leading Israeli provident and
Year-End Survey of Investment Transactions in Israel
With the 2016 fiscal year behind us, a number of reports that have been released in the past months provide a survey of the 2016 exits involving Israeli companies. The largest deal in 2016 that involved an Israeli company was the purchase of the Israeli tech company Playtika by the Giant Interactive Group from China
Invitation to Attend September Berlin Tech M&A Update
Software and Technology companies saw significant volume and valuation strength last year. But what impact will Brexit have on Tech M&A? What are the eight stages to get an optimal outcome in a M&A process? What are real deal disasters and how can you avoid them? Get an update on the latest trends, deal metrics
Materiality Provisions in Purchase Agreements
It is important for parties to a transaction who come from other less-litigious business environments to know that U.S. buyers and sellers operate in an environment where litigation is far more frequent, and even a single word can affect the outcome of a dispute. We believe that the example below (just one of many that
Greenberg Traurig Tel Aviv First Foreign Office to be Ranked by Israeli Legal Directories
Greenberg Traurig’s Tel Aviv office was recently ranked by BDICode, one of Israel’s leading legal directories . The office was included in tier 1 under the “International Commercial” practice area, and in tier 2 under the “Mergers & Acquisitions” practice area. Just several months ago, the Tel Aviv office was ranked by the other major
A Guide to Understanding Anti-Assignment Clauses
Introduction
With the increasing trend of globalization in the business world, Israeli companies and investors are commonly entering into agreements with U.S.-based entities. One of the most frequently found clauses in U.S. commercial agreements is an anti-assignment provision that prevents either or both of the parties from assigning the agreement to a third party prior
Teva buys Mexico’s Rimsa for US$2.3 billion
In
a recent deal that has been reported in press outlets around the globe, Israeli pharmaceuticals company Teva has purchased Mexican counterpart Rimsa for US$2.3 billion. Continue Reading.
Greenberg Traurig Team Represents Longtime Client OPKO Health in $1.47 Billion Merger Agreement
Israel Practice Co-Chair Bob Grossman led a multi-office team of Greenberg Traurig attorneys who represented longtime client OPKO HEALTH, INC. (NYSE:OPK) in the negotiation of a definitive merger agreement with Bio-Reference Laboratories, Inc. (NASDAQ:BRLI). OPKO is also traded as one of the largest companies on the Tel Aviv Stock Exchange. The $1.47 billion transaction, announced June 4, is expected to be completed during the second half of 2015.
OPKO is a multinational biopharmaceutical and diagnostics company. BRLI is considered one of the world’s largest and fastest-growing full-service diagnostic laboratories.
Continue Reading Greenberg Traurig Team Represents Longtime Client OPKO Health in $1.47 Billion Merger Agreement
Get Ready – Israeli M&A Deals Expected to Rise
According to a report by Nishlis Legal Marketing that was published in the American Lawyer’s Global M&A Guide 2015, the year 2014 was a lucrative year for Israeli M&A, with transactions totaling approximately $10.7 billion. This number is expected to rise as the number of Israeli technology and biomed companies, both attractive investments for
Greenberg Traurig to Host Webinar: ‘Doing M&A Deals in Israel’
Greenberg Traurig’s Tel Aviv office will be hosting a webinar “Doing M&A Deals in Israel” to be presented by Shareholder Joey T. Shabot. The discussion will review common transaction types and structures on cross-border U.S.-Israel deals; employment related matters, including a discussion of non-competes and non-solicits; the importance of obtaining a transaction specific tax